12/2022 B. Braun Medical Inc. Statement regarding cybersecurity vulnerabilities identified by the Openssl Project

Vulnerability Summary 

B. Braun is aware of the cybersecurity issues identified by the Openssl Project described in a recent press release outlining security vulnerability in the security-supporting library openssl/libopenssl. The issue impacts internet connections using HTTPS/TLS.

B. Braun proactively analyzed the potential issue and none of the B. Braun products listed below are impacted by any vulnerability outlined in the Openssl Project press release.

Product lines include:

• Outlook® Safety Infusion System Pump Family
• Space® Infusion Pump Family (Infusomat® Space® Infusion Pump, Perfusor® Space® Infusion Pump, SpaceStation, and Space® Wireless Battery)
• DoseTrac® Server, DoseLink™ Server, and Space® Online Suite Server software
• Pinnacle® Compounder
• APEX® Compounder

B. Braun ensures high security standards throughout the product life cycle by using globally accepted standard test and verification methods. It has established processes to monitor the latest vulnerabilities, threats, or risks and will proactively implement measures as required.

Further information can be found at the Department of Homeland Security Cybersecurity & Infrastructure Agency (CISA): https://us-cert.cisa.gov

Additional information: https://www.openssl.org/news/secadv/20221101.txt